Study guide

4.4 Diagnostic Angiography, Duplex Ultrasonography & Angiosome Concepts

Certified Wound Specialist Physician CWSP

Track your progress as you read

Finished sections get a check mark.

1 Introduction

About the CWSP Exam

2 Chapter 1: Integumentary Anatomy & Wound Healing Biology

1.1 Skin Anatomy, Microstructure & Epidermal-Dermal Barrier Function 1.2 Acute vs Chronic Wound Healing Phases & Cellular Kinetics 1.3 Extracellular Matrix Composition, Collagen Architecture & MMP Regulation

3 Chapter 2: Musculoskeletal & Neurologic Anatomy

2.1 Musculoskeletal Anatomy of the Leg & Foot 2.2 Neuroanatomy & Nerve Physiology for Wound Care

4 Chapter 3: Cell Signaling, Biofilm & Barriers to Healing

3.1 Growth Factors, Cytokines & Angiogenic Pathways 3.2 Biofilm Microbiology, Quorum Sensing & Phenotypic Resistance 3.3 Cellular Senescence, Hypoxia & Inflammatory Arrest 3.4 Metabolic, Steroid & Nutritional Impairments in Wound Healing

5 Chapter 4: Patient Evaluation & Vascular Diagnostics

4.1 Comprehensive Patient & Periwound Physical Examination 4.2 Noninvasive Macrovascular Hemodynamics: ABI, TBI & Segmental Pressures 4.3 Microvascular Perfusion Diagnostics: TcPO2, SPP & Near-Infrared Spectroscopy 4.4 Diagnostic Angiography, Duplex Ultrasonography & Angiosome Concepts

6 Chapter 5: Pain, Risk, Functional & Nutrition Assessment

5.1 Wound Pain Assessment 5.2 Risk Assessment Tools & Risk Stratification 5.3 Functional & Cognitive Assessment 5.4 Nutrition Screening & Assessment

7 Chapter 6: Imaging, Biopsy, Atypical Wounds & Neuropathy

6.1 Musculoskeletal Imaging for Osteomyelitis & Deep Space Infections 6.2 Diagnostic Tissue Biopsy, Culture Techniques & Quantitative Microbiology 6.3 Diagnostic Differential of Atypical & Malignant Ulcerations 6.4 Comprehensive Diabetic Peripheral Neuropathy & Biomechanical Assessment

8 Chapter 7: Wound Bed Preparation, Debridement, Dressings & Topical Agents

7.1 TIME Principle & Wound Bed Preparation Framework 7.2 Surgical, Sharp, Enzymatic, Autolytic & Biosurgical Debridement Modalities 7.3 Advanced Wound Dressings, Exudate Control & Moisture Balance 7.4 Topical Agents: Antiseptics, Antibiotics & Active Topicals

9 Chapter 8: Cellular & Tissue-Based Products, NPWT & Hyperbaric Oxygen

8.1 Cellular, Acellular & Matrix-Like Advanced Biologics (CTPs) 8.2 Negative Pressure Wound Therapy (NPWT) & Instillation Protocols 8.3 Hyperbaric Oxygen Therapy (HBOT): Mechanisms, Indications & Safety

10 Chapter 9: Biophysical Technologies: Electrical Stimulation & Ultrasound

9.1 Electrical Stimulation for Wound Healing 9.2 Therapeutic Ultrasound in Wound Care

11 Chapter 10: Revascularization, Antimicrobial Stewardship & Offloading

10.1 Revascularization for Limb Salvage 10.2 Systemic Antimicrobial Stewardship & Deep Infection Management 10.3 Mechanical Offloading, Pressure Redistribution & Total Contact Casting

12 Chapter 11: Surgical Closure & Healing Complications

11.1 Surgical Closure, Skin Grafts, Flaps & Amputation Levels 11.2 Managing Complications: Bleeding, Allergy, Adverse Events & Scarring

13 Chapter 12: Nutrition Therapy & Case Review

12.1 Nutrition Therapy for Wound Healing 12.2 Case Review: Synthesizing Data, Outliers & Prognosis

14 Chapter 13: Diabetic & Ischemic Lower-Extremity Wounds

13.1 Diabetic Foot Ulcers: Pathophysiology, Staging & Limb Salvage 13.2 Peripheral Arterial Disease & Ischemic Extremity Ulcerations 13.3 Mixed Arterial-Venous Disease & Complex Diagnostic Dilemmas

15 Chapter 14: Venous Disease, Pressure Injuries, Lymphedema & Edema

14.1 Venous Leg Ulcers, Chronic Venous Insufficiency & Compression 14.2 Pressure Injuries: NPIAP Staging, DTPI & Prevention 14.3 Lymphedema, Phlebolymphedema & Complete Decongestive Therapy 14.4 Edema: Systemic vs. Local Causes

16 Chapter 15: Inflammatory, Calcific, Medication-Induced & Dermatologic Wounds

15.1 Autoimmune & Inflammatory Ulcerations: Pyoderma Gangrenosum & Vasculitis 15.2 Calciphylaxis & Radiation Tissue Injury 15.3 Medication-Induced & Hematologic Atypical Wounds 15.4 Dermatologic Conditions That Cause or Complicate Wounds

17 Chapter 16: Traumatic Wounds, Burns & Frostbite

16.1 Traumatic Wounds: Lacerations, Bites, Degloving & Open Fractures 16.2 Thermal Burns & Frostbite

18 Chapter 17: Surgical, Infectious & Pediatric Wounds

17.1 Surgical Wounds, Surgical Site Infection & Dehiscence 17.2 Infectious Causes of Wounds: Necrotizing, Mycobacterial, Fungal & Other Infections 17.3 Pediatric Wound Care

19 Chapter 18: Reimbursement, Regulation & Documentation

18.1 CPT Coding, Modifiers & Documentation for Debridement and Biologics 18.2 Regulatory Compliance, CMS Quality Programs & Hospital-Acquired Conditions 18.3 Documentation, Legal Concepts & Confidentiality

20 Chapter 19: Ethics, Adherence, Epidemiology & Evidence-Based Practice

19.1 Clinical Ethics, Informed Consent & Palliative Wound Management 19.2 Patient Adherence & Psychosocial Care 19.3 Epidemiology of Chronic Wounds 19.4 Research Literacy, Evidence-Based Medicine & Quality Improvement

4.4 Diagnostic Angiography, Duplex Ultrasonography & Angiosome Concepts

Key Takeaways Explain This Topic AI

Diagnostic vascular imaging modalities involve critical clinical tradeoffs: Duplex ultrasonography provides noninvasive hemodynamic velocity ratios without contrast risk; CTA offers high-resolution 3D anatomical roadmaps but carries iodinated contrast-induced nephropathy and calcium bloom artifact; MRA eliminates radiation but carries the risk of Nephrogenic Systemic Fibrosis (NSF) in patients with eGFR <30 mL/min/1.73m²; and Digital Subtraction Angiography (DSA) remains the definitive interventional gold standard.

Duplex ultrasound defines arterial stenosis severity: a Peak Systolic Velocity (PSV) ratio >2.0 indicates ≥50% luminal stenosis, while a PSV ratio >3.5 indicates hemodynamically critical ≥75% stenosis.

The Angiosome Concept defines six discrete three-dimensional vascular territories of the foot and ankle supplied by primary branches of the anterior tibial, posterior tibial, and peroneal arteries.

Direct (angiosome-targeted) revascularization has been associated with better wound healing and limb salvage than indirect revascularization in several observational studies and meta-analyses, especially when the pedal arch is incomplete, although the evidence is not randomized.

The SVS WIfI system grades Wound, Ischemia, and foot Infection from 0 to 3 and combines them into clinical stages 1–4 that estimate 1-year major amputation risk (very low to high) and the likely benefit of revascularization.

Last updated: September 2026

4.4 Diagnostic Angiography, Duplex Ultrasonography & Angiosome Concepts

Core Clinical Principle: Successful limb salvage in Chronic Limb-Threatening Ischemia (CLTI) relies on precise anatomical imaging paired with physiological risk stratification. Understanding the diagnostic capabilities and toxicity profiles of Duplex Ultrasound, CTA, MRA, and catheter-directed Digital Subtraction Angiography (DSA) allows clinicians to formulate targeted revascularization strategies. By applying the Angiosome Concept (revascularizing the specific source artery feeding the ulcer bed) and the Society for Vascular Surgery (SVS) WIfI classification system (Wound, Ischemia, foot Infection), interdisciplinary limb salvage teams optimize wound healing rates and prevent major lower extremity amputations.

Comparative Analysis of Diagnostic Vascular Imaging Modalities

When noninvasive physiological screening (ABI, TBI, TcPO2, SPP) confirms arterial hypoperfusion, anatomical imaging is required to define lesion morphology, determine length and calcification of occlusions, assess distal runoff, and plan endovascular or surgical bypass reconstruction.

Imaging Modality Diagnostic Strengths & Resolution Clinical Risks & Contrast Toxicities Limitations & Image Artifacts

Duplex Ultrasonography (DUS) Noninvasive; zero radiation; zero nephrotoxicity; inexpensive. Combines anatomical B-mode imaging with real-time color Doppler and spectral velocity waveforms. Safe in severe chronic kidney disease (CKD) and end-stage renal disease (ESRD). Highly operator dependent. Acoustic shadowing from dense arterial calcification obscures luminal flow. Limited evaluation of infrapopliteal and pedal arch vessels.

Computed Tomography Angiography (CTA) Rapid volumetric acquisition; excellent spatial resolution (~0.5 mm); comprehensive 3D vascular roadmapping from abdominal aorta to digital arteries; visualizes extravascular anatomy (soft tissue gas, abscess, bone erosion). Contrast-Induced Nephropathy (CIN): Nephrotoxic risk from iodinated contrast. Avoid or hydrate aggressively in patients with eGFR <45 mL/min/1.73m². Anaphylactoid contrast reactions. Calcium Blooming Artifact: Severe circumferential medial calcification causes beam hardening, falsely exaggerating stenosis severity or obscuring patent lumina in diabetic and dialysis patients. Radiation exposure.

Magnetic Resonance Angiography (MRA) Excellent soft-tissue contrast; eliminates ionizing radiation; no iodinated contrast. Contrast-enhanced MRA (CE-MRA) provides high-resolution imaging of patent infrapopliteal runoff vessels. Nephrogenic Systemic Fibrosis (NSF): Debilitating, potentially fatal multiorgan fibrosing disorder triggered by gadolinium chelates in severe renal impairment. Black-box warning: Avoid in eGFR <30 mL/min/1.73m² or on dialysis. Contraindicated with non-MRI compatible pacemakers, ICDs, or ferromagnetic implants. Prone to motion artifact; overestimates stenosis due to intravoxel dephasing.

Digital Subtraction Angiography (DSA) Definitive gold standard. Highest temporal and spatial resolution for distal tibial and pedal arch anatomy. Enables simultaneous diagnostic imaging and endovascular therapeutic intervention (angioplasty, stenting, atherectomy). Invasive. Access site complications (hematoma, pseudoaneurysm, arteriovenous fistula, retroperitoneal hemorrhage). Distal atheroembolization ("trash foot"). Iodinated contrast nephrotoxicity (unless using C O 2 CO_2 C O 2 ​ ). Two-dimensional projection imaging. Requires specialized catheterization suite and experienced vascular interventionist.

Duplex Ultrasonography Stenosis Hemodynamic Criteria

Duplex criteria rely on the Peak Systolic Velocity (PSV) Ratio : PSV Ratio = PSV at Stenosis ( V 2 ) PSV in Normal Proximal Segment ( V 1 ) \text{PSV Ratio} = \frac{\text{PSV at Stenosis } (V_2)}{\text{PSV in Normal Proximal Segment } (V_1)} PSV Ratio = PSV in Normal Proximal Segment ( V 1 ​ ) PSV at Stenosis ( V 2 ​ ) ​

Normal / <50% Stenosis: PSV ratio <2.0; preserved triphasic flow; no significant spectral broadening.

≥50% Diameter Reduction Stenosis: PSV ratio >2.0 (velocity doubles across the lesion); marked spectral broadening filling the clear acoustic window beneath the systolic waveform peak, indicating disorganized, turbulent flow.

≥75% Critical Stenosis: PSV ratio >3.5 (or absolute local PSV >300 to 400 cm/s); pronounced post-stenotic flow turbulence and downstream blunted monophasic waveform with prolonged rise time (parvus et tardus waveform).

Occlusion: Complete absence of detectable Doppler flow within the imaged arterial segment; presence of pre-occlusive "thump" waveform and distal collateral reconstitution.

Contrast-Induced Nephropathy (CIN) Prevention Protocol

Contrast-induced acute kidney injury is defined as an absolute serum creatinine elevation ≥0.5 mg/dL or a relative increase ≥25% over baseline occurring 48 to 72 hours following iodinated contrast administration without an alternative etiology. For high-risk patients (CKD Stage 3b or worse with eGFR <45 mL/min/1.73m², diabetic nephropathy, congestive heart failure):

Discontinue potential nephrotoxic medications (NSAIDs, aminoglycosides, amphotericin B) at least 48 hours prior.

Withhold metformin at the time of procedure and for 48 hours post-procedure to avert catastrophic lactic acidosis should acute renal failure supervene.

Administer intravenous isotonic 0.9% normal saline at 1.0 to 1.5 mL/kg/hour for 12 hours prior to and 12 hours following the procedure (or a rapid protocol of 3 mL/kg/hour for 1 hour pre-procedure and 1 to 1.5 mL/kg/hour for 4 to 6 hours post-procedure).

In severe renal failure, utilize Carbon Dioxide ( C O 2 CO_2 C O 2 ​ ) Digital Subtraction Angiography as a negative-contrast agent for infra-diaphragmatic imaging (contraindicated above the diaphragm due to risk of cerebral air embolism).

Nephrogenic Systemic Fibrosis (NSF) Pathophysiology

When gadolinium-based contrast agents (GBCAs)—specifically older linear chelate formulations—are administered to patients with severe renal failure (eGFR <30 mL/min/1.73m² or on dialysis), prolonged biological elimination half-life (extended from 1.5 hours to >30–120 hours) promotes transmetallation. Toxic free gadolinium ( G d 3 + Gd^{3+} G d 3 + ) ions dissociate from the chelate, precipitating in cutaneous and visceral tissues. Circulating fibrocytes are recruited, stimulating massive collagen deposition, severe dermal induration (producing a "peau d'orange" woody texture), irreversible joint flexion contractures, and fatal visceral fibrosis of the myocardium and lungs. Gadolinium-enhanced MRA is strictly avoided in patients with eGFR <30 mL/min/1.73m² .

The Angiosome Concept in Lower Extremity Limb Salvage

Introduced in 1987 by plastic surgeons G. Ian Taylor and Mark Palmer , the Angiosome Concept anatomical model divides the human body into three-dimensional vascular blocks comprising skin, subcutaneous tissue, fascia, muscle, and bone, each supplied by a specific source artery and drained by accompanying veins.

The Six Foot & Ankle Angiosomes

The foot and ankle are supplied by three main infrapopliteal parent arteries (Anterior Tibial, Posterior Tibial, and Peroneal), which subdivide into six distinct anatomical angiosomes : ANTERIOR / DORSAL VIEW PLANTAR / POSTERIOR VIEW

  • [ Anterior Tibial Artery ] [ Posterior Tibial Artery ]
  • | |
  • v +---------+---------+
  • (Dorsalis Pedis Artery) | |
  • | v v
  • v (Medial Plantar) (Lateral Plantar)
  • [ DORSUM OF FOOT ] | |
  • [ Dorsal Toes 1-5 ] v v
  • [ MEDIAL INSTEP ] [ PLANTAR FOREFOOT ]
  • [ Plantar Hallux] [ Plantar Heads 2-5]

LATERAL & HEEL BRANCHES:

  • Posterior Tibial -> Calcaneal Branch ----------> [ MEDIAL HEEL / SOLE ]
  • Peroneal Artery -> Calcaneal Branch -----------> [ LATERAL HEEL ]
  • Peroneal Artery -> Ant. Perforating Branch ----> [ LATERAL ANKLE / DORSOLATERAL ]

Anterior Tibial Artery (ATA) → \rightarrow → Dorsalis Pedis Artery (DPA):

Supplies: Entire dorsum of the foot, dorsal aspect of all digits, and anterior ankle joint.

Posterior Tibial Artery (PTA) → \rightarrow → Calcaneal Branch:

Supplies: Medial heel, plantar aspect of the heel, and posterior-inferior calcaneus.

Posterior Tibial Artery (PTA) → \rightarrow → Medial Plantar Artery (MPA):

Supplies: Medial instep of the sole, medial plantar arch, and plantar aspect of the hallux.

Posterior Tibial Artery (PTA) → \rightarrow → Lateral Plantar Artery (LPA):

Supplies: Lateral plantar midfoot and forefoot, plantar metatarsal heads 2 through 5, and plantar surfaces of the lateral four digits. Forms the deep plantar arterial arch.

Peroneal Artery (PA) → \rightarrow → Calcaneal Branch:

Supplies: Lateral heel and posterior-inferior lateral calcaneal margin.

Peroneal Artery (PA) → \rightarrow → Anterior Perforating Branch:

Supplies: Lateral anterior ankle, sinus tarsi region, and proximal dorsolateral foot.

Direct vs. Indirect Angiosome-Targeted Revascularization

In diabetic neuroischemic ulcers and CLTI, endovascular therapy or surgical bypass can restore perfusion along different pathways:

Direct Revascularization (DR): Endovascular recanalization or surgical bypass that restores direct, straight-line, pulsatile arterial flow into the specific source artery feeding the anatomical angiosome containing the active ulcer.

Indirect Revascularization (IR): Revascularization of an adjacent source artery feeding a different angiosome, relying on collateral "choke vessels" (inter-angiosome microvascular connections) to transmit flow retrogradely into the ulcer bed.

Clinical Evidence & Outcomes in Diabetic Limb Salvage

Observational studies and meta-analyses generally favor direct revascularization over indirect revascularization (randomized evidence is lacking):

Wound Healing: Pooled observational data show higher wound healing rates with direct revascularization than with indirect revascularization, although reported percentages vary widely between studies.

Time to Healing: Several cohorts report faster healing after direct revascularization.

Limb Salvage & Major Amputation: Major amputation-free survival is significantly higher in DR cohorts, especially in dialysis and diabetic patients.

The Crucial Role of the Pedal Arch

Inter-angiosome collateral flow relies heavily on the pedal arterial arch (anastomosis between the deep plantar artery of the dorsalis pedis and the lateral plantar artery of the posterior tibial system).

When the Pedal Arch is Complete and Patent: Indirect revascularization achieves clinical healing rates approaching direct revascularization because blood flows unimpeded across macrovascular conduits.

When the Pedal Arch is Diseased, Incomplete, or Occluded (Common in Diabetes): Collateral choke vessels are narrow, diseased, or thrombosed. In this clinical scenario, indirect revascularization frequently fails , and direct revascularization of the specific target angiosome artery is mandatory for limb salvage.

Society for Vascular Surgery (SVS) WIfI Classification System

To standardize amputation risk stratification and quantify the expected clinical benefit of revascularization in Chronic Limb-Threatening Ischemia (CLTI), the Society for Vascular Surgery (SVS) established the WIfI Classification System based on three independent prognostic axes: Wound (W) , Ischemia (I) , and foot Infection (fI) .

WIfI Grading Parameters (Scores 0 to 3 for Each Axis)

Grade Wound (W) Criteria Ischemia (I) Criteria (ABI / Toe Pressure / TcPO2) foot Infection (fI) Criteria (IDSA / IWGDF)

0 No ulcer; ischemic rest pain only. ABI ≥0.80 ; Toe Pressure ≥60 mmHg; TcPO2 ≥60 mmHg Uninfected. No symptoms or signs of inflammation or purulence.

1 Minor, shallow tissue loss. Small ulcer on distal foot or leg; no exposed tendon, bone, or joint. No gangrene. ABI 0.60–0.79 ; Toe Pressure 40–59 mmHg; TcPO2 40–59 mmHg Mild. Local infection involving skin and subcutaneous tissue only; erythema >0.5 cm but ≤2 cm from ulcer edge; no deep tissue involvement; no systemic signs.

2 Deeper ulcer with exposed tendon, bone, or joint; or gangrenous changes limited to digits. Shallow calcaneal ulcer without salvage risk. ABI 0.40–0.59 ; Toe Pressure 30–39 mmHg; TcPO2 30–39 mmHg Moderate. Erythema >2 cm, or infection involving deep tissues (abscess, osteomyelitis, septic arthritis, necrotizing fasciitis); patient is systemically well (no SIRS).

3 Extensive, deep ulcer involving hindfoot or midfoot; extensive full-thickness necrosis; or gangrene extending proximal to metatarsophalangeal joints. ABI <0.40 ; Toe Pressure <30 mmHg; TcPO2 <30 mmHg Severe. Infection with systemic inflammatory response syndrome (SIRS): ≥2 of: Temp >38°C or <36°C; HR >90 bpm; RR >20 bpm; WBC >12,000 or <4,000/µL or >10% bands.

Composite Clinical Staging & Clinical Decision Pathways

By cross-referencing the Wound (0–3), Ischemia (0–3), and foot Infection (0–3) grades in the validated SVS matrix, patients are assigned to one of four clinical stages that directly dictate the 1-year risk of major amputation and the expected benefit of revascularization :

Clinical Stage 1: Very low estimated 1-year amputation risk.

Clinical Stage 2: Low estimated risk.

Clinical Stage 3: Moderate estimated risk.

Clinical Stage 4: High estimated risk; revascularization benefit is often greatest when ischemia drives the stage (a separate "stage 5" describes an unsalvageable foot).

The stages come from an expert Delphi consensus matrix. In a pooled review of validation cohorts (2,970 limbs), weighted 1-year major amputation rates were about 3%, 7%, 9%, and 25% for stages 1 through 4, with wide variation between studies.

Loading diagram... The Six Foot/Ankle Angiosomes and SVS WIfI Clinical Decision Framework